Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
| Business Activity | PASS |
| Debt Ratio | N/A |
| Cash Ratio | N/A |
| Receivables Ratio | N/A |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
$328.5M
8.21
0.316
12
$71.6M
$24.3M
1.27
11.69
0.2%
260
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($31.17, 12 analysts) | |||
| 10 | $102.40 | +$209.30 (204%) | 13.6R |
| 50 | $512.00 | +$1,046.50 (204%) | 13.6R |
| 100 | $1,024.00 | +$2,093.00 (204%) | 13.6R |
- Elevated short interest (11.69 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| XNCR | 0.460 |
| IMNM | 0.443 |
| ARKG | 0.436 |
| CLDX | 0.434 |
| NRIX | 0.431 |
| Ticker | Correlation |
|---|---|
| PRFX | -0.178 |
| BAES.L | -0.160 |
| AMC.AX | -0.159 |
| 5218.KL | -0.125 |
| BJ | -0.124 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.